Act Local, Act Global⁎⁎Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology. Inflammation and the Multiplicity of “Vulnerable” Coronary Plaques by Libby, Peter
EA
I
t
“
P
B
A
P
C
o
c
c
a
t
e
o
o
“
i
“
t
a
a
f
n
g
p
m
t
u
t
a
d
v
c
“
R
i
v
A
m
B
H
H
Journal of the American College of Cardiology Vol. 45, No. 10, 2005
© 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00
Pm
l
d
f
i
H
s
P
s
d
t
a
c
o
t
t
e
s
i
(
p
s
i
T
h
s
g
w
m
(
r
c
c
n
a
I
F
W
t
(
(
w
m
s
p
m
l
t
I
k
p
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.02.058DITORIAL COMMENT
ct Local, Act Global*
nflammation and
he Multiplicity of
Vulnerable” Coronary Plaques
eter Libby, MD, FACC
oston, Massachusetts
REVOLUTION IN OUR THINKING REGARDING THE
ATHOGENESIS OF ACUTE CORONARY SYNDROMES
ontemporary clinical and laboratory data have challenged
ur classical concepts of the pathogenesis of the acute
oronary syndromes. Indeed, several independent lines of
linical evidence have shown that critical stenoses cause only
fraction of acute coronary syndromes (1). Rather, disrup-
ions due to fibrous cap fracture or superficial intimal
rosion frequently trigger acute coronary thromboses at sites
f non-critical narrowing of coronary arteries. This shift in
ur thinking has fostered the notion of the so-called
vulnerable” or “high-risk” plaque (2,3) and spawned man-
fold attempts to develop methods for detection of the
vulnerable” plaque (4), a quest predicated on the postulate
hat local intervention could preclude plaque thrombosis
See pages 1585 and 1594
nd possibly prevent acute coronary syndromes. Indeed, this
pproach may prove applicable to patients already targeted
or invasive diagnosis or treatment in whom identification of
onstenotic lesions unseen by traditional angiography might
uide a local intervention aimed at prophylaxis that may
revent a future coronary event. An acute coronary event
arks a patient for a high short-term risk of recurrence and
hus justifies such an aggressive stance. Moreover, individ-
als with stable coronary artery disease in drug intervention
rials require many months or even years of treatment to
chieve event reduction (5), hence the interest in an imme-
iate invasive intervention that might “stabilize” potentially
ulnerable plaques despite the challenge of designing a
linical trial to prove the benefit of such an approach.
VULNERABLE PLAQUES”: SINGLE OR MULTIPLE?
apidly accumulating clinical data suggest that a search to
dentify a single vulnerable plaque to guide local therapy
*Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the Donald W. Reynolds Cardiovascular Clinical Research Center, Depart-
ent of Medicine, Brigham and Women’s Hospital and Harvard Medical School,
oston, Massachusetts. This work was funded in part by grants from the Nationalt
eart, Lung, and Blood Institute (Bethesda, Maryland) to Dr. Libby (HL-34636 and
L-56985) and the Fondation Leducq.ay seriously underestimate the complexity of the chal-
enge. We traditionally view atherosclerosis as a segmental
isease. Indeed, flow-limiting stenoses do occur focally,
urnishing a foundation for the success of revascularization
n relieving angina pectoris and other ischemic symptoms.
owever, the more we seek, the more we see that athero-
clerosis most often extends beyond the segmental stenoses.
atients whose burden of disease includes flow-limiting
tenoses usually harbor diffuse but angiographically unseen
isease along the length of their arteries. Thus, the coronary
ree may veritably teem with plaques at high risk of rupture
nd thrombosis (6).
Although well-suited to pinpoint stenoses, traditional
ontrast coronary arteriography affords only an indirect view
f aspects of atheromata related to their propensity to
rigger thromboses. For every culprit lesion, other poten-
ially troublesome plaques may lurk undetected (6). Yet,
ven this relatively insensitive tool of angiography often
hows a multiplicity of already disrupted or complex plaques
n patients with acute coronary syndromes. Goldstein et al.
7) found angiographic features of instability of nonculprit
laques in nearly 40% of patients with acute coronary
yndromes and further demonstrated a more dire prognosis
n those with such findings. Others (8–12), including
anaka et al. (12), as described in this issue of the Journal,
ave used intracoronary ultrasonography to seek more direct
tructural evidence of disruption remote from the angio-
raphically apparent culprit lesions in a series of patients
ith acute coronary syndromes. Many such patients have
ore than one disrupted plaque detected echographically
Fig. 1). The autopsy study by Mauriello et al. (13), also
eported in this issue of the Journal, provides pathoanatomi-
al confirmation of this concept. They found plaques with
haracteristics of vulnerability in almost a quarter (22.3%) of
on–infarct-related arteries in patients who succumbed to
cute myocardial infarction (13).
NFLAMMATION FANS THE
LAME OF PLAQUE VULNERABILITY
e now recognize inflammation as a common contributor
o the acute thrombotic manifestations of atherosclerosis
14). As gauged by the robust biomarker C-reactive protein
CRP), inflammation predicts the prognosis of individuals
ith acute coronary syndromes and also those without
anifest atherosclerosis (15). This predictive power of CRP
eems independent of the overall plaque burden and of the
alette of traditional risk factors encompassed by the Fra-
ingham algorithm. Pathophysiological studies have estab-
ished many mechanistic links between inflammation and
he thrombotic complications of atherosclerosis (Fig. 2).
nflammatory mediators not only elevate levels of biomar-
ers such as CRP but also unleash pathways that weaken the
laque’s fibrous cap, set the stage for superficial erosion of
he intima, promote procoagulant production, and quench
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May 17, 2005:1600–2 Editorial Commentndogenous fibrinolysis (Fig. 2). Because of hepatic over-
roduction of acute-phase reactants such as fibrinogen,
lasminogen activator inhibitor-1, and even CRP itself, the
egulation of thrombosis by inflammatory mediators occurs
ot only in the local “solid state” of the plaque but in the
uid phase of blood as well. Both new studies on the
ulticentricity of vulnerable plaques reported within this
ssue of the Journal buttress the link between inflammation
nd plaque instability (12,13). C-reactive protein measured
ne month after an acute coronary syndrome correlates with
he number of ruptured plaques observed by ultrasonogra-
hy during the event (12). Although this relationship may
igure 1. Prevalence of multiple coronary artery plaque ruptures detected
y intravascular ultrasonography (IVUS) in five studies. Interrogation of
oronary arteries of patients with acute coronary syndromes by IVUS
eveals coincident ruptures of nonculprit lesions in 13% to 79% of cases.
he differences in the prevalence of multiple plaque ruptures among studies
ay depend on technical issues (e.g., use of contrast), patient selection,
iming of the investigation with relation to the index event, and other
ariables (8–12).
igure 2. Mechanisms by which inflammation can promote plaque disruptio
yndromes depends on plaque disruption and the thrombotic/fibrinolytic b
egulates two major mechanisms of plaque disruption: a frank fracture of the
ediators also influence the thrombotic/fibrinolytic balance of both the plaqueeflect inflammation as a consequence rather than cause of
laque instability, it nonetheless strengthens the case that
inks inflammation and the vulnerability of atheromata.
Biomarker studies show that inflammation in the coro-
ary tree of patients with acute coronary syndromes extends
ell beyond the site of the culprit lesion. The autopsy study
y Mauriello et al. (13) underscores previous clinical find-
ngs in intact patients using myeloperoxidase as an index of
nflammation (16). At autopsy, histopathologic hallmarks of
nflammation characterize both culprit and non–infarct-
elated plaques in coronary arteries of those with fatal
yocardial infarction. Coronary plaques in those who died
oncoronary deaths tended to show lesser signs of inflam-
ation (13).
LINICAL IMPLICATIONS OF THE
ULTICENTRICITY OF POTENTIALLY
NSTABLE ATHEROMATA: ACT LOCAL, ACT GLOBAL
ow should this snowballing evidence regarding inflamma-
ion and the multicentricity of potentially dangerous plaques
nform our practice? Clearly, early invasive management,
ncluding local intervention on the culprit lesion in conjunc-
ion with contemporary pharmacologic “adjuvants,” can
mprove outcomes of many with acute coronary syndromes.
till, recurrent cardiovascular events in this population
emain unacceptably high. We must think not only locally,
xed by our traditional focus on the culprit lesion, but also
onsider globally the other vulnerable plaques in the coro-
ary and other arteries of patients with acute coronary
yndromes. The results of Tanaka et al. (12) and Mauriello
t al. (13) add to the compelling case that beyond local
herapy targeting today’s culprit lesion, all at-risk individuals
the acute coronary syndromes. The pathophysiology of the acute coronary
e of the plaque’s “solid state” and the blood’s “fluid phase.” Inflammationn and
alancfibrous cap and superficial erosion of the intimal surface. Inflammatory
and the blood.
a
t
t
o
s
r
o
c
t
w
t
t
a
c
R
a
B
h
R
1
1
1
1
1
1
1
1
1602 Libby JACC Vol. 45, No. 10, 2005
Editorial Comment May 17, 2005:1600–2lso should have lifestyle and often pharmacologic interven-
ion to “stabilize” plaques remote from the culprit lesion,
hus curtailing recurrent events and improving long-term
utcomes. Although reduction in coronary events in the
tatin “megatrials” of stable or apparently well populations
equires many months or years of treatment, recent studies
f aggressive statin administration to those with acute
oronary syndromes have shown remarkably rapid reduc-
ions in recurrent event rates (17). Thus, acting “locally”
ith appropriate revascularization and “globally” with sys-
emic treatments to address the multicentric plaques and
heir inflammatory basis may well afford an optimum
pproach to therapy of patients who present with acute
oronary syndromes.
eprint requests and correspondence: Dr. Peter Libby, Brigham
nd Women’s Hospital, 77 Avenue Louis Pasteur, NRB 741,
oston, Massachusetts 02115. E-mail: plibby@rics.bwh.
arvard.edu.
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